These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22863661)

  • 1. The financial impact of a state adopting a personal/philosophical belief exemption policy: modeling the cost of pertussis disease in infants, children and adolescents.
    Wells KB; Omer SB
    Vaccine; 2012 Sep; 30(41):5901-4. PubMed ID: 22863661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence.
    Omer SB; Pan WK; Halsey NA; Stokley S; Moulton LH; Navar AM; Pierce M; Salmon DA
    JAMA; 2006 Oct; 296(14):1757-63. PubMed ID: 17032989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic models for health economic assessments of pertussis vaccines: what goes around comes around...
    Rozenbaum MH; De Cao E; Westra TA; Postma MJ
    Expert Rev Vaccines; 2012 Dec; 11(12):1415-28. PubMed ID: 23252386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographic clustering of nonmedical exemptions to school immunization requirements and associations with geographic clustering of pertussis.
    Omer SB; Enger KS; Moulton LH; Halsey NA; Stokley S; Salmon DA
    Am J Epidemiol; 2008 Dec; 168(12):1389-96. PubMed ID: 18922998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical literature review of health economic evaluations in pertussis booster vaccination.
    Millier A; Aballea S; Annemans L; Toumi M; Quilici S
    Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):71-94. PubMed ID: 22280198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. United States private schools have higher rates of exemptions to school immunization requirements than public schools.
    Shaw J; Tserenpuntsag B; McNutt LA; Halsey N
    J Pediatr; 2014 Jul; 165(1):129-33. PubMed ID: 24795202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic analysis of pertussis illness in the Dutch population: implications for current and future vaccination strategies.
    de Greeff SC; Lugnér AK; van den Heuvel DM; Mooi FR; de Melker HE
    Vaccine; 2009 Mar; 27(13):1932-7. PubMed ID: 19368774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pertussis vaccine--an analysis of benefits, risks and costs.
    Koplan JP; Schoenbaum SC; Weinstein MC; Fraser DW
    N Engl J Med; 1979 Oct; 301(17):906-11. PubMed ID: 39253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pertussis vaccination strategies for neonates--an exploratory cost-effectiveness analysis.
    Scuffham PA; McIntyre PB
    Vaccine; 2004 Jul; 22(21-22):2953-64. PubMed ID: 15246632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis.
    Purdy KW; Hay JW; Botteman MF; Ward JI
    Clin Infect Dis; 2004 Jul; 39(1):20-8. PubMed ID: 15206048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pertussis control in the Asia-Pacific region: a report from the Global Pertussis Initiative.
    Forsyth K; Thisyakorn U; von König CH; Tan T; Plotkin S;
    Southeast Asian J Trop Med Public Health; 2012 May; 43(3):699-711. PubMed ID: 23077850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost of epidemiological transition: a study of a decrease in pertussis vaccination coverage.
    Girard DZ
    Health Policy; 2005 Nov; 74(3):287-303. PubMed ID: 15951048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic impact of the introduction of an acellular pertussis vaccine in Canada: a 6-year analysis.
    Iskedjian M; De Serres G; Einarson TR; Walker JH
    Vaccine; 2010 Jan; 28(3):714-23. PubMed ID: 19895923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Religious exemptions for immunization and risk of pertussis in New York State, 2000-2011.
    Imdad A; Tserenpuntsag B; Blog DS; Halsey NA; Easton DE; Shaw J
    Pediatrics; 2013 Jul; 132(1):37-43. PubMed ID: 23733795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public health perspectives on the rising incidence of pertussis.
    Judelsohn RG; Koslap-Petraco MB
    Public Health Nurs; 2007; 24(5):421-8. PubMed ID: 17714226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative.
    Forsyth KD; Campins-Marti M; Caro J; Cherry JD; Greenberg D; Guiso N; Heininger U; Schellekens J; Tan T; von König CH; Plotkin S;
    Clin Infect Dis; 2004 Dec; 39(12):1802-9. PubMed ID: 15578403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccination against whooping cough is beneficial for health economics. Results of a model analysis].
    Norlund A; Kornfält R; Lithman T
    Lakartidningen; 1996 Mar; 93(13):1252-6. PubMed ID: 8656844
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic evaluation of an extended acellular pertussis vaccine programme for adolescents in Ontario, Canada.
    Iskedjian M; Walker JH; Hemels ME
    Vaccine; 2004 Oct; 22(31-32):4215-27. PubMed ID: 15474711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foolish vaccine exemptions.
    N Y Times Web; 2006 Oct; ():A28. PubMed ID: 17061340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.